Beremagene geperpavec

Vyjuvek 5×10^9 plaquevormende eenheden/ml suspensie en gel voor gel

GelNetherlandsAuthorisedAuthorised 23 Apr 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VyjuvekEuropean UnionAuthorised

Vyjuvek 5 X 10E9 Unidades Formadoras de Placas/ML en Suspension y Gel Para Preparacion de GelSpain · 5x10e9 Unidades formadoras de placa/Mililitro · suspension y gel para gel · Krystal Biotech Netherlands B.V.Same brand
VyjuvekEuropean Union · Krystal Biotech Netherlands B.V.Same brand
VyjuvekCroatiaSame brand
VyjuvekUnited States · 5.0x10^9 PFU/mL · Gel · Krystal Biotech, Inc.Same brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Beremagene geperpavec

Vyjuvek 5×10^9 plaquevormende eenheden/ml suspensie en gel voor gel

GelNetherlandsAuthorisedAuthorised 23 Apr 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VyjuvekEuropean UnionAuthorised

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Beremagene geperpavec
Dosage form: Gel
Route: Cutaan gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 23 Apr 2025
Registration: EU/1/25/1918
Marketing authorisation holder: Krystal Biotech Netherlands B.V.
ATC code: D03AX16
Group: Dermatologicals
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006330
EU number: EU/1/25/1918